Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,520 | 10,503 | 29,425 | 3,692 | 5,640 |
| Marketable Securities | 86,872 | 86,090 | 81,456 | 2,021 | 7,210 |
| Receivables | 1,555 | 947 | 560 | N/A | 21 |
| TOTAL | $112,782 | $101,053 | $113,277 | $9,308 | $16,297 |
| Non-Current Assets | |||||
| PPE Net | 13,814 | 13,306 | 13,114 | 13,858 | 14,611 |
| Investments And Advances | 110,236 | 46,893 | 50,609 | 0 | 0 |
| Other Non-Current Assets | 11,639 | 11,559 | 6,449 | 6,963 | 7,213 |
| TOTAL | $135,689 | $71,757 | $70,172 | $20,821 | $21,823 |
| Total Assets | $248,471 | $172,810 | $183,448 | $30,130 | $38,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,545 | 3,146 | 2,955 | 2,622 | 2,520 |
| Accrued Expenses | 5,387 | 6,584 | 6,850 | 7,092 | 6,056 |
| TOTAL | $9,852 | $10,681 | $10,793 | $10,677 | $9,653 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,289 | 7,512 | 4,419 | 4,236 | 3,821 |
| TOTAL | $11,370 | $10,634 | $7,581 | $7,436 | $7,059 |
| Total Liabilities | $21,222 | $21,316 | $18,374 | $18,113 | $16,713 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,464 | 50,951 | 47,607 | 10,411 | 9,292 |
| Common Shares | 8 | 5 | 5 | 1 | 1 |
| Retained earnings | -129,764 | -110,895 | -94,034 | -139,480 | -129,366 |
| Other shareholders' equity | 256 | 665 | 550 | 463 | 367 |
| TOTAL | $227,248 | $151,494 | $165,074 | $12,016 | $21,408 |
| Total Liabilities And Equity | $248,471 | $172,810 | $183,448 | $30,130 | $38,120 |